2002: Emanuel Petricoin III, PhD

Director of the Center for Applied Proteomics and Molecular Medicine

 

Emanuel Petricoin III, PhD
Director of the Center for Applied Proteomics and Molecular Medicine
George Mason University

"Dr. Emanual Petricoin III joined the FDA in 1993, following a three-year postgraduate fellowship with the agency. He currently is senior investigator in the Office of Cell Tissue and Gene Therapies in the Center for Biologics Evaluation and Research. Petricoin holds a doctorate in microbiology from the University of Maryland at College Park. He begins his appointment April 1.

Together with Dr. Lance Liotta, he has formed the Center for Applied Proteomics and Molecular Medicine. The Center has formed a unique partnership between George Mason and Inova Health System. George Mason University-Inova Health System Translational Research Centers is a joint initiative to coordinate multiple programs to implement proteomics, nanotechnology, and genomics research in cancer, metabolic syndrome, cardiopulmonary diseases, and neurodegenerative and liver diseases. This initiative comprises the research efforts of three shared centers: the Center for Applied Proteomics and Molecular Medicine; the Center for Biomedical Genomics; and the Center for the Study of Genomics of Liver Diseases. Inova and George Mason have combined efforts to recruit internationally renowned scientists, such as Lance Liotta and Emanuel Petricoin III, to work closely with clinical investigators from Inova.

Research in the Center will focus on the discovery and identification of biomarkers—biological indicators of cellular function in body fluids—for early disease detection and risk assessment, and the analysis of molecular pathways in diseased tissue to determine individualized and targeted treatment for patients. Results of the research will then be translated directly into patient management and care through clinical research and innovative clinical trials, with a vision toward creating a new paradigm to personalize medical treatment, resulting in a positive impact on public health." - Patty Snellings, Mason Gazette, Wednesday, March 9th, 2005

 

This information was copied from www.gmu.edu/departments/lifesciences/proteomics/petricoin.htm on August 14, 2006